Starpharma Holdings Limited (OTCMKTS:SPHRY – Get Free Report)’s share price was down 9.1% on Thursday . The stock traded as low as $0.51 and last traded at $0.51. Approximately 120 shares were traded during mid-day trading, a decline of 92% from the average daily volume of 1,539 shares. The stock had previously closed at $0.56.
Starpharma Stock Down 9.1%
The firm’s 50-day simple moving average is $0.58 and its 200-day simple moving average is $0.65. The company has a debt-to-equity ratio of 0.07, a quick ratio of 4.58 and a current ratio of 4.94.
About Starpharma
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.
See Also
- Five stocks we like better than Starpharma
- Business Services Stocks Investing
- Is Meta Plotting a Stablecoin Comeback Years After Libra’s Flop?
- 3 Warren Buffett Stocks to Buy Now
- Silver’s Options Sizzle: Are Traders Betting on a Breakout?
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio?
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
